Clinical Trial Update: A Comparison of Measurements of Ketone Body Flux Versus Ketone Body Concentration as a Pharmacodynamic Marker of Hepatic Fatty Acid Oxidation (0000-110) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial comparing measurements of ketone body flux versus ketone body concentration as pharmacodynamic markers of hepatic fatty acid oxidation in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes | Phase 1 | Status: COMPLETED